Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Phase I Clinical Trial News Monitoring

Get by Email • RSS

Published on May 22, 2025

Gene therapy for X-linked retinoschisis promising in phase 1/2 trial

Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Seven of nine treated eyes achieved closure of foveal schisis …

Source: Healio News - Neutral
Published on May 22, 2025

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized ...

24-month follow-up data from randomized Phase I part of the Phase I/II trial of TG4050 in resected locally advanced head and neck cancer selected for rapid oral presentation at ASCO on June 1st, 2025 Strasbourg, France, May 22, 2025, 5:45 p.m. CET – …

Distribution channels: Media, Advertising & PR ...
Published on May 22, 2025

Bayer initiates phase I study with GIRK4 inhibitor for treatment of patients with atrial fibrillation

Bayer announced initiation of a phase I clinical trial with BAY 3670549, an investigational highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, which has the potential to help control the electrical activity of …

Source: Pharmabiz.com - Neutral
Published on May 22, 2025

AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA)...

TAIPEI, May 21, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its …

Source: WFMZ - Pennsylvania - Neutral
Published on May 22, 2025

Clinical Trial Shows Improvements for Spinal Cord Injuries

In a new clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The University of Texas at Dallas demonstrated unprecedented rates of recovery for spinal cord injuries. In this study, published in the journal Nature on May 21, …

Source: ScienceDaily - Pending
Published on May 23, 2025

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate ...

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage …

Source: WFMZ - Pennsylvania - Neutral
Published on May 23, 2025

Chong Kun Dang to receive 1st milestone payment from Novartis for rare disease drug candidate CKD-510

Chong Kun Dang, a Korean pharmaceutical company, said it will receive a $5 million milestone payment from Novartis related to the investigational rare disease treatment CKD-510. CKD-510 is an orally administered, highly selective histone deacetylase 6 ( …

Source: Korea Biomedical Review - Neutral
Published on May 21, 2025

VNS Clinical Trial Shows Improvements for Spinal Cord Injuries

The leadership group for the Texas Biomedical Device Center includes, from left, Dr. Michael Kilgard, Dr. Jane Wigginton, Dr. Seth Hays and Dr. Robert Rennaker. In a new clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The …

Source: University of Texas - Pending
Published on May 21, 2025

Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas ...

BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 22, 2025

Chong Kun Dang Receives First Milestone Payment for Drug Candidate Licensed to Novartis

Chong Kun Dang announced on may 22 that it will receive a milestone payment of $5 million (approximately 6.9 billion won) for its rare disease drug candidate, “CKD-510,” which was licensed to Swiss pharmaceutical giant Novartis. This marks the first …

Source: Business Korea - Neutral
Published on May 20, 2025

Oral therapy for glaucoma, dry AMD passes phase 1 milestone with promising results

Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Galimedix Therapeutics reported oral GAL-101 completed the …

Source: Healio News - Neutral
Published on May 20, 2025

First Subject Dosed For Phase 1/3 Clinical Trial Of Henlius' Proposed Ipilimumab Biosimilar

Shanghai Henlius Biotech, Inc. announced that the first subject was dosed for a phase 1/3 clinical trial of the company's independently developed ipilimumab biosimilar HLX13 (recombinant anti-CTLA-4 fully human monoclonal antibody injection) in …

Source: Biosimilar Development - Pending
Published on May 22, 2025

Pfizer Pledges $1.25B for Drug Candidate in Promising But Competitive Area of Immunotherapy

Pfizer’s top cancer drugs are small molecules, but dealmaking has expanded the pharmaceutical giant’s portfolio and pipeline with biologic medicines. Its latest deal puts the pharmaceutical giant in a camp of companies that have turned to China for the …

Source: MedCity News - Neutral
Published on May 20, 2025

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis

NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the first patient in a Phase 1/2 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 20, 2025

Aptose Announces Dosing of First Patient with 120 mg of Tuspetinib in Phase 1/2 Tuscany Trial of Frontline Triple Drug ...

TUS+VEN+AZA triplet achieves complete remissions (CRs) and minimal residual disease (MRD)-negativity with favorable safety in newly diagnosed AML patients Completed 40 mg and 80 mg TUS dose cohorts; no prolonged myelosuppression or dose-limiting toxicities …

Distribution channels: Technology ...
Published on May 23, 2025

Boundless Bio Announces Portfolio Prioritization and Runway Extension

Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 21, 2025

New Orleans biotech advances non-opioid pain drug

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South Angels (GSA), the region’s leading angel investor …

Source: New Orleans City Business - Louisiana - Neutral
Published on May 21, 2025

ASX biotechs drive paediatric drug advances

Australia has become well-known for its paediatric drug discovery with several life-altering treatments CSL is a global leader in developing therapies for children with haemophilia and other serious blood disorders Neurotech International is at forefront …

Source: Cairns Post - Neutral
Published on May 23, 2025

Pursuing Bladder Cancer Treatments, Reducing Side Effects

Newswise — When enfortumab vedotin (now known as Padcev) was initially approved by the FDA in 2019 for use in patients with advanced or metastatic urothelial cancer, it was the first real breakthrough seen in the treatment of bladder cancer in decades. The …

Source: Newswise - Neutral

02 days 16:04:35

Featured Releases

Got News to Share? · Submit · See All

Published on May 23, 2025 - 20:05 GMT

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 08:25 GMT

Barentz strengthens its pharmaceuticals market presence in APAC through the envisaged acquisition of Fengli in China

SINGAPORE, May 23, 2025 /⁨EINPresswire.com⁩/ -- Barentz, a leading global specialty ingredients solutions provider, has entered into exclusive discussions to acquire 100% equity of Fengli Group, one of the market-leading specialty chemicals distributors …

Distribution channels: Business & Economy, Chemical Industry ...

Published on May 23, 2025 - 06:30 GMT

Global Acetyl Serine Market Set for Robust Growth Amid Rising Demand in Pharmaceutical and Nutraceutical Applications

UK acetyl serine market grows steadily, driven by pharma expansion and biotech R&D, with key use in drug formulations and therapeutic applications. NEWARK, DE, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- The acetyl serine market is …

Distribution channels: Chemical Industry ...
Published on May 23, 2025 - 01:48 GMT

Pharmaceutical Secondary Packaging Market to Reach USD 72.8 Billion by 2035, Driven by Compliance and Brand Innovation

Smart packaging with QR codes, RFID, and tamper-evident seals drives USA pharma secondary packaging demand, ensuring safety, compliance, and traceability. NEWARK, DE, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- The global pharmaceutical …

Distribution channels: Business & Economy ...

Published on May 23, 2025 - 12:00 GMT

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …

Distribution channels:
Published on May 23, 2025 - 19:36 GMT

DiaGen Ai Inc. Announces JV with Contango Labs to Launch its First Decentralized Drug Discovery Miner on Bittensor $TAO

DiaGen Ai Inc., Announces Partnership with Contango Labs and Provides Update and Upsizing of its Seed Unit Financing VANCOUVER, BC, CANADA, May 23, 2025 /⁨EINPresswire.com⁩/ -- DiaGen Ai Inc., Announces Partnership with Contango Labs Launching its …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 23, 2025 - 16:36 GMT

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before ...

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on May 23, 2025 - 13:19 GMT

Radiopharmaceuticals Market Growth, Trends & Opportunities 2025 | DataM Intelligence

Radiopharmaceuticals Market involves radioactive drugs used for diagnosis and treatment of diseases, especially cancer and neurological disorders. AUSTIN, TX, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- The Global Radiopharmaceuticals …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 815,730,777 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 24, 2025 - 00:00 GMT

Now Accepting Applications: iHope Genetic Health Clinical Sites

Pass it on! DAMASCUS, MD, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Genetic Alliance is now accepting applications for new clinical sites to join the iHope Genetic Health (iGH) program, which provides no-cost genomic testing to families from low …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 23:28 GMT

ACHS Welcomes My Vinyasa Practice as a New Marketplace Partner

ACHS partners with My Vinyasa Practice to expand wellness education access & offer exclusive benefits that support holistic health careers & lifelong learning. PORTLAND, OR, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- American …

Distribution channels: Business & Economy, Consumer Goods ...
Published on May 23, 2025 - 20:32 GMT

New Book ‘The Healthiest Human’ Offers Science-Based Guide to Optimal Wellness

“The Healthiest Human: The Guide to Optimal Health and Wellness” by Guy Millward Now Available on Amazon and Digital Platforms UNITED KINGDOM, May 23, 2025 /⁨EINPresswire.com⁩/ -- “The Healthiest Human: The Guide to Optimal Health and Wellness,” a new …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on May 23, 2025 - 20:07 GMT

Sample Sale Spectacle: Murray Hill Optical Launches with Weeklong Event Featuring Deep Discounts and Designer Finds

Score designer frames up to 80% off during Murray Hill Optical’s grand opening sample sale, May 28–June 4 at 500 3rd Ave, NYC. Style, prizes, and vision await! NEW YORK, NY, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- A Fresh Start, A Limited-Time …

Distribution channels: Business & Economy, Consumer Goods ...
Published on May 24, 2025 - 07:49 GMT

Vorläufige Ergebnisse von Merus zu Petosemtamab mit Pembrolizumab zeigen robuste Wirksamkeit und Dauerhaftigkeit bei der ...

- 63%ige Ansprechrate bei 24 auswertbaren Patienten beobachtet - 79%ige Gesamtüberlebensrate nach 12 Monaten; 9 Monate medianes progressionsfreies Überleben - Telefonkonferenz am Donnerstag, 22. Mai, um 17:30 Uhr (Eastern Time) UTRECHT, Niederlande, und …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 07:49 GMT

Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent une réelle efficacité...

- Taux de réponse de 63 % observé chez les 43 patients évaluables - Taux de survie général de 79 % au bout de 12 mois ; survie sans progression de niveau moyen à 9 mois - Conférence téléphonique le jeudi 22 mai à 17 h 30 heure de l’Est UTRECHT, Pays-Bas et …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 19:36 GMT

DiaGen Ai Inc. Announces JV with Contango Labs to Launch its First Decentralized Drug Discovery Miner on Bittensor $TAO

DiaGen Ai Inc., Announces Partnership with Contango Labs and Provides Update and Upsizing of its Seed Unit Financing VANCOUVER, BC, CANADA, May 23, 2025 /⁨EINPresswire.com⁩/ -- DiaGen Ai Inc., Announces Partnership with Contango Labs Launching its …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 23, 2025 - 18:57 GMT

OmniShield Remains a Phoenix Mobilizer for the Phoenix Society for Burn Survivors

Continuing More Than A Decade of Giving DALLAS, TX, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- The mission statement of OmniShield is to "Protect the World... one family at a time." The network of distributors carry high-quality early …

Distribution channels: Companies, Consumer Goods ...
Published on May 23, 2025 - 18:47 GMT

Community Health Provider Aims to Make Health Care More Accessible

Affordable Behavioral Health Care is Hard to Find in Smaller, Underserved Communities DALLAS, TX, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Memorial Day is a time when the nation pauses to honor the courage of our heroes, including those …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 23, 2025 - 18:45 GMT

Ideal Physical Therapy and Fitness Integrates Spinal Decompression and Physical Therapy for Holistic Pain Relief

Ideal Physical Therapy and Fitness delivers non-invasive relief in Naples by uniting spinal decompression, physical therapy, and fitness under one roof. NAPLES, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Ideal Physical Therapy and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Sports, Fitness & Recreation ...
Published on May 23, 2025 - 18:21 GMT

Elimu Informatics Launches RapidFireApps™ to Accelerate Innovation for Healthcare Startups

New service fast-tracks the launch of clinician and patient apps by combining FHIR expertise, pre-built components, and seamless EHR integration. EL CERRITO, CA, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Elimu Informatics is proud to …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on May 23, 2025 - 17:42 GMT

ACCESS Specialty Animal Hospital Expands Outreach with First-of-Its-Kind K9 Emergency Training for First Responders

ACCESS Specialty Animal Hospital Trains First Responders with Hands-On K9 Emergency Training at Palm Beach State College Invitational. ROYAL PALM BEACH, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- ACCESS Specialty Animal Hospital – Palm Beach …

Distribution channels: Education, Emergency Services ...
Published on May 23, 2025 - 17:38 GMT

DEF Biologic & Small Molecule CME Bootcamps Invite Attendees to 'Master the Magic of Treatment Selection'

The longest-running, continuously updated, in-person meeting for dermatology NPs & PAs focuses on diagnosis and treatment of inflammatory skin diseases. MONTCLAIR, NJ, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Offering attendees the …

Distribution channels: Conferences & Trade Fairs, Education ...
Published on May 23, 2025 - 17:34 GMT

OmniShield Remains A Sustaining Member of The National Volunteer Fire Council

Home Safe Network Continues Sponsorship into 2026 DALLAS, TX, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- According to UL and other experts, we can have as little as 3 minutes from the start of a fire in a modern home to the flashover …

Distribution channels: Building & Construction Industry, Education ...
Published on May 23, 2025 - 17:21 GMT

Orlando Dentist Dr. Cuong T. Phan Now VA-Certified to Provide Dental Care to Eligible Veterans

ORLANDO, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Veterans in Central Florida now have expanded access to dental care as Dr. Cuong T. Phan of Phan-tastic Smiles has officially received certification from the U.S. Department of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
Published on May 23, 2025 - 17:10 GMT

Armanite Launches WarehouseStop.com, Expanding Its Housewares Legacy and Embracing the Growing Chemical Industry

WEST PALM BEACH, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Armanite, a Florida-based company with a proven track record as a power seller in the housewares category on Amazon, proudly announces the launch of its new e-commerce …

Distribution channels: Automotive Industry, Chemical Industry ...
Published on May 23, 2025 - 16:26 GMT

Mainstreaming Women's Health in Congress with the First-Ever Women's Health Capitol Hill Day

First-ever Women's Health Capitol Hill Day includes Congressional Briefing with Experts Highlighting Gaps and Opportunities to Advance the Health of Women WASHINGTON, DC, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- On May 21st, Women’s …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 23, 2025 - 16:15 GMT

Woman who reversed chronic illness Celebrated as Shining Star in Zumba's Global Campaign

Woman who reversed chronic illness Celebrated as Shining Star in Zumba's Global Campaign SANTA BARBARA, CA, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Santa Barbara’s Josette Tkacik, known as one of the world's most successful …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 16:10 GMT

Specialized AI Writing Tools Challenge ChatGPT Market Dominance

Business-focused solutions like Eskritor capitalize on enterprise workflow gaps as ChatGPT's market share faces competitive pressure. TURKEY, May 23, 2025 /⁨EINPresswire.com⁩/ -- The AI writing tools market is undergoing a fundamental …

Distribution channels: Consumer Goods, Education ...
Published on May 23, 2025 - 16:03 GMT

R3 Stem Cell Publishes Podcast Called Stem Cell Genius to Educate Consumers on Regenerative Medicine

The world's largest provider of regenerative therapies, R3 Stem Cell, has launched a new podcast called Stem Cell Genius. SCOTTSDALE, AZ, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- The world's largest provider of regenerative therapies, …

Distribution channels: Beauty & Hair Care, Business & Economy ...